PB 15 of 2014

I, ADRIANA PLATONA,  Assistant Secretary, Pharmaceutical Evaluation Branch, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this determination under subsection 85AB(1) of the National Health Act 1953.

Dated           19                February 2014

Part 1         Preliminary

1              Name of Determination

         (1)   This Determination is the National Health (Listed drugs on F1 or F2) Amendment Determination 2014 (No. 1).

         (2)   This Determination may also be cited as PB 15 of 2014.

2              Commencement

                This Determination commences on 1 March 2014.

3              Amendment of National Health (Listed drugs on F1 or F2) Determination 2010

                Schedule 1 amends the National Health (Listed drugs on F1 or F2) Determination 2010 (PB 93 of 2010).

Schedule 1             Amendments

(Section 3)

[1]     Schedule 1, after item dealing with Aprepitant

Insert

Arachidonic acid and docosahexaenoic acid with carbohydrate

[2]     Schedule 1, after item dealing with Carbimazole

Omit

Carbohydrate, fat, vitamins, mineral and trace elements

Insert

Carbohydrate, fat, vitamins, minerals and trace elements

Carbohydrate, fat, vitamins, minerals and trace elements and supplemented with arachidonic acid and docosahexaenoic acid

[3]     Schedule 1, after item dealing with Disopyramide

Insert

Docosahexaenoic acid with carbohydrate

[4]     Schedule 1, after item dealing with Trifluoperazine

Insert

Triglycerides, long chain